How can I see more cases or information for products?

Please leave your contacts at your convenience Send us your brands and models, we are pleased to be helpful.

Lh58 Lyse for Mindray Hematology Analyzer Bc 58 Series Reagents

Name: Lh58 Lyse for Mindray Hematology Analyzer Bc 58 Series Reagents
Brand: Zhejiang Xinke Medical Technology Co., Ltd.
SKU: 2155220965

Zhejiang, ChinaZhejiang Xinke Medical Technology Co., Ltd.

US$1.00

1 Piece

Sample price:US$1.00/piece.Request sample

Product profile

Customization

Available

Type

IVD Reagent

Product Type

Hematology Analyzer Reagent

Model NO.

JXK-224

Reagents Classification

Class I

Item Type

Mindray

Applicable Model

Mindray Bc1800 Bc2300 Bc2600 Bc2800 Bc3000 Bc3200

Certificate

ISO9001&13485&CE&Free Sale Certificate

After-Sales Service

Online Technical Support

Capacity

500 Cartons Per Day

Transport Package

Cartons and Pallet

Specification

500ml

Trademark

xinke

Origin

China

HS Code

3822009000

Production Capacity

500 Cartons Per Day

Key features

100% Compatibility: Fully compatible with original Mindray hematology analyzer reagents.

OEM Service Available: Flexible customization and OEM services are supported.

Quality Assurance: Every batch undergoes quality testing and final inspection before shipping.

Sample Availability: Samples are offered for comparison testing upon request.

Multiple Certifications: Certified with ISO9001, ISO13485, CE, and Free Sale Certificate.

Wide Model Support: Suitable for Mindray BC-5200, BC-5500, BC-5600, and BC-5800 series.

High Production Capacity: Capable of producing 500 cartons per day.

Company profile

Importers and ExportersYears of Export Experience

Zhejiang Xinke Medical Technology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: OEM Service Available CertifiedCustomization Options: Flexible customization CertifiedExport Year: 20 Years CertifiedNearest Port: Ningbo PortAverage Response Time: ≤3.16h

AI-Powered supplier vetting

SummaryThe supplier operates in the clinical in vitro diagnostic reagent field and reports ten years of ISO9001 and ISO13485 quality-system certification. It offers flexible customization, has OEM experience with well-known brands, possesses self-managed import/export rights, and has exported for 20 years, with exports representing 51%–70% of total sales. Quality inspection procedures are documented and consistently followed, while stated lead times are within 15 working days in both peak and off-season. However, the supplier reports no inventory, overseas warehouse, overseas showroom, overseas agents or branches, offline trade-show participation, ODM service, SDK, recent new-product development, ERP, OA, CRM, SAP, or broader digitalization initiatives. Financial information is inconsistent or insufficiently interpretable in the provided records, so financial credibility cannot be determined.

Supplier typeThe supplier identifies itself as a company in the clinical in vitro diagnostic reagent field and has self-managed import/export rights with 20 years of export experience. This supports classification as an export-capable manufacturer or supplier in the medical in vitro diagnostics sector.

CertificationsThe company states that it has maintained ISO9001 and ISO13485 quality-system certifications for ten years. These explicitly documented certifications support a positive assessment of its quality-system credentials.

R&D capabilityThe supplier reports no new products in the past year, no ODM service, no available SDK, and no current enterprise digitalization or technical-transformation plan. These explicit limitations indicate weak demonstrated innovation capability.

Customization capabilityThe supplier explicitly provides flexible customization through both its R&D and design-service capabilities. This directly supports a positive assessment of customization capability, although ODM service is not offered.

Client casesThe supplier states that it provides OEM services for well-known brands, which is evidence of relevant customer experience. No specific brand names, project details, or verifiable case descriptions are provided, so the evidence is positive but limited.